Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.

Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG, Chang-Claude J, Hein R, Lurie G, Wilkens LR, Carney ME, Goodman MT, Moysich K, Kjaer SK, Hogdall E, Jensen A, Goode EL, Fridley BL, Larson MC, Schildkraut JM, Palmieri RT, Cramer DW, Terry KL, Vitonis AF, Titus LJ, Ziogas A, Brewster W, Anton-Culver H, Gentry-Maharaj A, Ramus SJ, Anderson AR, Brueggmann D, Fasching PA, Gayther SA, Huntsman DG, Menon U, Ness RB, Pike MC, Risch H, Wu AH, Berchuck A; Ovarian Cancer Association Consortium..

Lancet Oncol. 2012 Apr;13(4):385-94. doi: 10.1016/S1470-2045(11)70404-1. Epub 2012 Feb 22.

2.

Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.

Sieh W, Salvador S, McGuire V, Weber RP, Terry KL, Rossing MA, Risch H, Wu AH, Webb PM, Moysich K, Doherty JA, Felberg A, Miller D, Jordan SJ; Australian Cancer Study (Ovarian Cancer).; Australian Ovarian Cancer Study Group., Goodman MT, Lurie G, Chang-Claude J, Rudolph A, Kjær SK, Jensen A, Høgdall E, Bandera EV, Olson SH, King MG, Rodriguez-Rodriguez L, Kiemeney LA, Marees T, Massuger LF, van Altena AM, Ness RB, Cramer DW, Pike MC, Pearce CL, Berchuck A, Schildkraut JM, Whittemore AS; Ovarian Cancer Association Consortium..

Int J Epidemiol. 2013 Apr;42(2):579-89. doi: 10.1093/ije/dyt042.

3.

Reproductive characteristics in relation to ovarian cancer risk by histologic pathways.

Merritt MA, De Pari M, Vitonis AF, Titus LJ, Cramer DW, Terry KL.

Hum Reprod. 2013 May;28(5):1406-17. doi: 10.1093/humrep/des466. Epub 2013 Jan 12.

4.

[Endometriosis as a risk factor for ovarian cancer].

Vargas-Hernández VM.

Cir Cir. 2013 Mar-Apr;81(2):163-8. Review. Spanish.

PMID:
23522320
5.

Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis.

Buis CC, van Leeuwen FE, Mooij TM, Burger CW; OMEGA Project Group..

Hum Reprod. 2013 Dec;28(12):3358-69. doi: 10.1093/humrep/det340. Epub 2013 Sep 5.

PMID:
24014607
6.

Prevalence of endometriosis in malignant epithelial ovary tumours.

Oral E, Ilvan S, Tustas E, Korbeyli B, Bese T, Demirkiran F, Arvas M, Kosebay D.

Eur J Obstet Gynecol Reprod Biol. 2003 Jul 1;109(1):97-101.

PMID:
12818453
7.

Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study.

Erzen M, Rakar S, Klancnik B, Syrjänen K.

Gynecol Oncol. 2001 Oct;83(1):100-8. Erratum in: Gynecol Oncol 2001 Dec;83(3):617. Klancar B [corrected to Klancnik B].

PMID:
11585420
8.

Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.

Modugno F, Ness RB, Allen GO, Schildkraut JM, Davis FG, Goodman MT.

Am J Obstet Gynecol. 2004 Sep;191(3):733-40.

PMID:
15467532
9.

Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.

Bjørnholt SM, Kjaer SK, Nielsen TS, Jensen A.

Hum Reprod. 2015 Jan;30(1):222-31. doi: 10.1093/humrep/deu297. Epub 2014 Nov 5.

PMID:
25376453
10.

Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?

Jordan SJ, Green AC, Whiteman DC, Webb PM; Australian Ovarian Cancer Study Group..

Gynecol Oncol. 2007 Nov;107(2):223-30. Epub 2007 Jul 27.

PMID:
17662378
11.

Epithelial ovarian cancers and endometriosis.

Acién P, Velasco I, Acién M, Capello C, Vela P.

Gynecol Obstet Invest. 2015;79(2):126-35. doi: 10.1159/000367597. Epub 2015 Jan 27.

PMID:
25634648
12.

Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.

Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH; Australian Cancer Study (Ovarian Cancer).; Australian Ovarian Cancer Study Group., Risch HA, Yu H, Doherty JA, Chang-Claude J, Hein R, Nickels S, Wang-Gohrke S, Goodman MT, Carney ME, Matsuno RK, Lurie G, Moysich K, Kjaer SK, Jensen A, Hogdall E, Goode EL, Fridley BL, Vierkant RA, Larson MC, Schildkraut J, Hoyo C, Moorman P, Weber RP, Cramer DW, Vitonis AF, Bandera EV, Olson SH, Rodriguez-Rodriguez L, King M, Brinton LA, Yang H, Garcia-Closas M, Lissowska J, Anton-Culver H, Ziogas A, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Webb PM; Ovarian Cancer Association Consortium..

Endocr Relat Cancer. 2013 Mar 22;20(2):251-62. doi: 10.1530/ERC-12-0395. Print 2013 Apr.

13.

Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience.

Mangili G, Bergamini A, Taccagni G, Gentile C, Panina P, Viganò P, Candiani M.

Gynecol Oncol. 2012 Sep;126(3):403-7. doi: 10.1016/j.ygyno.2012.05.007. Epub 2012 May 15.

PMID:
22609111
14.

Prevalence of Endometriosis in Malignant Epithelial Ovarian Tumor.

Akbarzadeh-Jahromi M, Shekarkhar G, Sari Aslani F, Azarpira N, Heidari Esfahani M, Momtahan M.

Arch Iran Med. 2015 Dec;18(12):844-8. doi: 0151812/AIM.009.

15.

Body size and risk of epithelial ovarian and related cancers: a population-based case-control study.

Olsen CM, Nagle CM, Whiteman DC, Purdie DM, Green AC, Webb PM; Australian Cancer Study (Ovarian Cancer) and Australian Ovarian Cancer Study Group..

Int J Cancer. 2008 Jul 15;123(2):450-6. doi: 10.1002/ijc.23509.

16.

Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery.

Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS.

Cancer Causes Control. 2008 Dec;19(10):1357-64. doi: 10.1007/s10552-008-9207-9. Epub 2008 Aug 14.

17.

Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies.

Faber MT, Kjær SK, Dehlendorff C, Chang-Claude J, Andersen KK, Høgdall E, Webb PM, Jordan SJ; Australian Cancer Study (Ovarian Cancer).; Australian Ovarian Cancer Study Group., Rossing MA, Doherty JA, Lurie G, Thompson PJ, Carney ME, Goodman MT, Ness RB, Modugno F, Edwards RP, Bunker CH, Goode EL, Fridley BL, Vierkant RA, Larson MC, Schildkraut J, Cramer DW, Terry KL, Vitonis AF, Bandera EV, Olson SH, King M, Chandran U, Kiemeney LA, Massuger LF, van Altena AM, Vermeulen SH, Brinton L, Wentzensen N, Lissowska J, Yang HP, Moysich KB, Odunsi K, Kasza K, Odunsi-Akanji O, Song H, Pharaoh P, Shah M, Whittemore AS, McGuire V, Sieh W, Sutphen R, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Pearce CL, Wu AH, Pike MC, Risch HA, Jensen A; Ovarian Cancer Association Consortium..

Cancer Causes Control. 2013 May;24(5):989-1004. doi: 10.1007/s10552-013-0174-4. Epub 2013 Mar 2.

18.

Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.

Cuff J, Longacre TA.

Am J Surg Pathol. 2012 May;36(5):688-95. doi: 10.1097/PAS.0b013e31824b6eed.

PMID:
22498820
19.

Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies.

Collaborative Group on Epidemiological Studies of Ovarian Cancer., Beral V, Gaitskell K, Hermon C, Moser K, Reeves G, Peto R.

Lancet Oncol. 2012 Sep;13(9):946-56. doi: 10.1016/S1470-2045(12)70322-4. Epub 2012 Aug 3. Review.

20.

Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer.

Merritt MA, Green AC, Nagle CM, Webb PM; Australian Cancer Study (Ovarian Cancer).; Australian Ovarian Cancer Study Group..

Int J Cancer. 2008 Jan 1;122(1):170-6.

Supplemental Content

Support Center